| Impact of prophylactic human papillomavirus vaccines on dermatology and venereology. | |
| | |
MedLine Citation:
|
PMID: 18833082 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Prophylactic HPV L1 VLP quadrivalent and bivalent vaccines have a great importance for patients seen by dermatologists and venereologists. Both vaccines protect against HPV16- and HPV 18-associated anogenital cancers, as well as cancers of the mouth, the upper respiratory tract and skin, especially of the fingers and periungual region. The quadrivalent HPV6, 11, 16, 18 vaccine also prevents anogenital warts (condylomata acuminata) which are the most common benign tumors of this body region. HPV-vaccination (Gardasil) has been approved in Germany and other European Countries since October 2006 for young girls between 9-16 and young women between 16-26 years of age. Many experts feel that boys and young men should also be vaccinated. Men would profit from a vaccine that protects against HPV infections, especially anogenital warts, as well as penile and anal carcinomas. In immunosuppressed organ transplant recipients and HIV-positive patients. HPV disease can be widespread, chronic and often may rapidly progress to malignant tumors. Thus, these individuals would greatly benefit from prophylactic HPV immunization. |
| | |
Authors:
|
G Gross |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Giornale italiano di dermatologia e venereologia : organo ufficiale, Società italiana di dermatologia e sifilografia Volume: 143 ISSN: 0392-0488 ISO Abbreviation: G Ital Dermatol Venereol Publication Date: 2008 Aug |
Date Detail:
|
Created Date: 2008-10-03 Completed Date: 2008-12-19 Revised Date: 2012-07-30 |
Medline Journal Info:
|
Nlm Unique ID: 8102852 Medline TA: G Ital Dermatol Venereol Country: Italy |
Other Details:
|
Languages: eng Pagination: 259-65 Citation Subset: IM |
Affiliation:
|
Department of Dermatology and Venereology, University of Rostock, Rostock, Germany. gerd.gross@med.uni-rostock.de |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Adult Alphapapillomavirus* / drug effects, immunology Anus Neoplasms / prevention & control, virology Condylomata Acuminata / prevention & control, virology Dermatology / trends* Female Humans Male Papilloma / prevention & control, virology Papillomavirus Infections / prevention & control*, virology Papillomavirus Vaccines / therapeutic use* Penile Neoplasms / prevention & control, virology Primary Prevention* / methods Respiratory Tract Neoplasms / prevention & control, virology Sex Factors Sexually Transmitted Diseases, Viral / prevention & control Skin Diseases, Viral / prevention & control* Venereology / trends* Vulvar Neoplasms / prevention & control, virology Young Adult |
| Chemical | |
Reg. No./Substance:
|
0/Papillomavirus Vaccines; 0/human papillomavirus vaccine L1, type 6,11,16,18 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Melanoma and pregnancy.
Next Document: A case of Klippel-Trenaunay syndrome involving only upper limbs.